Liaoning Chengda Biotechnology Co. Ltd. Class ASSE: 688739

Announcement on Obtaining Drug Registration Certificate for Quadrivalent Influenza Vaccine (Split Virion) and Passing GMP Compliance Inspection for Drugs

· Issued by Liaoning Chengda Biotechnology Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Drug Registration Certificate for Quadrivalent Influenza Vaccine (Split Virion) and Passing GMP Compliance Inspection for Drugs

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis

Earlier from Liaoning Chengda Biotechnology Co. Ltd. Class A

All Liaoning Chengda Biotechnology Co. Ltd. Class A news releases